Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...

Afrezza is a rapid-acting inhaled human insulin indicated to improve glycemic control in adults with diabetes mellitus.

MannKind (Nasdaq:MNKD) announced today that it received FDA approval, updating the prescribing information for Afrezza ...

Medtronic said Monday it received 510 (k) clearance from the Food and Drug Administration for an app to connect its smart ...

Lyumjev (insulin lispro-aabc) is prescribed to manage blood sugar levels in certain people with type 1 or 2 diabetes. The drug comes as a liquid solution for injection as directed by your doctor. The ...

Artificial intelligence (AI) can match physician insulin dosing, maintaining target blood sugar levels in patients with type 2 diabetes. A study showed an AI-based insulin decision support system's ...

Afrezza (insulin human) is a brand-name inhaled insulin prescribed to manage blood sugar in adults with diabetes. It comes as a powder that you typically take at mealtimes. The dosage can vary based ...

The FDA cleared the first automated insulin dosing device for adults with type 2 diabetes, the agency announced on Monday. An interoperable automated glycemic controller, Insulet's SmartAdjust ...

Afrezza (insulin human) is prescribed to help manage blood sugar in adults with diabetes. The drug comes as powder with a cartridge and device for inhaling. You take it at the beginning of each meal.